Active Ingredient: LOTEPREDNOL ETABONATE
Proprietary Name: EYSUVIS
Dosage Form; Route of Administration: SUSPENSION/DROPS; OPHTHALMIC
Strength: 0.25%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N210933
Product Number: 001
Approval Date: Oct 26, 2020
Applicant Holder Full Name: ALCON LABORATORIES INC
Marketing Status:
Prescription
Patent and Exclusivity Information
